BioMimetic (BMTI) Receives FDA Panel Backing For Augment Bone Graft

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. SPY
3. EL
4. ADI
5. ROST
6. BILL
7. WMT
8. MRK
9. MRNA
10. MRVL

Go back to BioMimetic (BMTI) Receives FDA Panel Backing For Augment Bone Graft
BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) Delayed: 9.49 --0 (-0%)
Previous Close $9.49    52 Week High $9.56 
Open $9.49    52 Week Low $2.01 
Day High $9.49    P/E N/A 
Day Low $9.49    EPS $-0.97 
Volume 1,100